- Kristi Powers
Anderson Ata is a typical 10-year-old who likes playing basketball and hanging out with his friends, but on New Year’s Eve he got really sick.
“I took a couple of covers from my cabinet and put them on me, waited about an hour and I was still shaking and I didn’t know what was happening,” Anderson Ata explained to FOX 35 News Anchor Amy Kaufeldt.
Doctors diagnosed Anderson with early stages of Type 1 diabetes. The family was referred to Dr. Konda Reddy to administer the life-changing monoclonal antibody treatment. Anderson became the seventh patient in the world, and the first in Orlando, to receive the new FDA-approved drug called Tzield.
To determine eligibility for the treatment, a simple blood test is performed. TZIELD, is the first drug that can delay the progression of Type 1 diabetes by up to three years in adults and up to eight years in children.
AdventHealth was a part of a large global research study which led to TZIELD gaining FDA-approval. When TZIELD became available on the market at the beginning of the year, AdventHealth was one of a handful of hospital systems administering the groundbreaking treatment.
Learn more about how the treatment is given and how Anderson is doing post treatment, here.
Choose the health content that’s right for you, and get it delivered right in your inbox.
Recent News
We were thrilled to take part in this year’s Clay County Days, where our team proudly showcased an incredible float.
Lisa Rose of Palm Coast had more than one reason to smile as she marked her 65th birthday in the intensive care unit (ICU), surrounded by balloons, cheesecake and the care team that helped her reach...
AdventHealth breaks ground on city’s first ER, bringing 24/7 care to residents.
AdventHealth President/CEO David Banks defines the "Love Me" service standard and reveals how it brings the organization's mission to life.
Dr. Myron St. Louis recently celebrated performing the leading-edge Transcarotid artery revascularization on his 200th patient at AdventHealth Sebring.
Minimally invasive Aquablation® therapy treatment is available at UChicago Medicine AdventHealth Bolingbrook.
AdventHealth is pleased to introduce Scott Girard, DO, to our community. He is joining our team at AdventHealth Medical Group Multispecialty at South Asheville
Scott Girard, DO, is an experienced, board-certified internist dedicated to providing patient-centered care.
Caring for underinsured and uninsured members of the community is just one of the many ways we give back to the community.
Emotional reunion between ER care team and patient.
Quick-thinking patient care technician Mireya Torrealba saved a choking patient at AdventHealth East Orlando by performing the Heimlich maneuver.
AdventHealth Waterman is one of only 36 hospitals nationwide to earn recognition from the American Diabetes Association and Leapfrog.